$EGLT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Zyla Life Sciences.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Zyla Life Sciences. Get notifications about new insider transactions in Zyla Life Sciences for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 22 2020 | EGLT | Zyla Life Sciences | CR Group L.P. | 10% Owner | Option Exercise | D | 0.00 | 2,436,459 | 244 | 0 | |
May 22 2020 | EGLT | Zyla Life Sciences | CR Group L.P. | 10% Owner | Sell | D | 0.00 | 4,586,874 | 0 | 0 | 4.6 M to 0 (-100.00 %) |
May 21 2020 | EGLT | Zyla Life Sciences | McInnis Joe | Director | Sell | D | 0.00 | 26,953 | 0 | 0 | 27 K to 0 (-100.00 %) |
May 21 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Option Exercise | D | 1.50 | 116,400 | 174,600 | 0 | |
May 21 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Sell | D | 0.00 | 180,864 | 0 | 0 | 180.9 K to 0 (-100.00 %) |
May 21 2020 | EGLT | Zyla Life Sciences | Walbert Timothy P | Director | Sell | D | 0.00 | 26,953 | 0 | 0 | 27 K to 0 (-100.00 %) |
May 21 2020 | EGLT | Zyla Life Sciences | Smiley Andrea Heslin | Director | Sell | D | 0.00 | 26,953 | 0 | 0 | 27 K to 0 (-100.00 %) |
May 21 2020 | EGLT | Zyla Life Sciences | Phillips Gary M. | Director | Sell | D | 0.00 | 33,620 | 0 | 0 | 33.6 K to 0 (-100.00 %) |
May 21 2020 | EGLT | Zyla Life Sciences | Pauls Matthew | Director | Sell | D | 0.00 | 26,953 | 0 | 0 | 27 K to 0 (-100.00 %) |
May 21 2020 | EGLT | Zyla Life Sciences | SMITH TODD N | President and CEO | Option Exercise | D | 2.37 | 180,000 | 426,600 | 0 | |
May 21 2020 | EGLT | Zyla Life Sciences | SMITH TODD N | President and CEO | Option Exercise | D | 1.50 | 241,500 | 362,250 | 0 | |
May 21 2020 | EGLT | Zyla Life Sciences | SMITH TODD N | President and CEO | Sell | D | 0.00 | 365,500 | 0 | 0 | 365.5 K to 0 (-100.00 %) |
Apr 24 2020 | EGLT | Zyla Life Sciences | Walbert Timothy P | Director | Option Exercise | M | 0.00 | 6,667 | 0 | 13,333 | |
Apr 24 2020 | EGLT | Zyla Life Sciences | Walbert Timothy P | Director | Payment of Exercise | F | 1.75 | 952 | 1,666 | 5,715 | 6.7 K to 5.7 K (-14.28 %) |
Apr 24 2020 | EGLT | Zyla Life Sciences | Walbert Timothy P | Director | Buy | M | 1.75 | 6,667 | 11,667 | 6,667 | 0 to 6.7 K |
Apr 24 2020 | EGLT | Zyla Life Sciences | Smiley Andrea Heslin | Director | Option Exercise | M | 0.00 | 6,667 | 0 | 13,333 | |
Apr 24 2020 | EGLT | Zyla Life Sciences | Smiley Andrea Heslin | Director | Payment of Exercise | F | 1.75 | 952 | 1,666 | 5,715 | 6.7 K to 5.7 K (-14.28 %) |
Apr 24 2020 | EGLT | Zyla Life Sciences | Smiley Andrea Heslin | Director | Buy | M | 1.75 | 6,667 | 11,667 | 6,667 | 0 to 6.7 K |
Apr 24 2020 | EGLT | Zyla Life Sciences | Pauls Matthew | Director | Option Exercise | M | 0.00 | 6,667 | 0 | 13,333 | |
Apr 24 2020 | EGLT | Zyla Life Sciences | Pauls Matthew | Director | Payment of Exercise | F | 1.75 | 952 | 1,666 | 5,715 | 6.7 K to 5.7 K (-14.28 %) |
Apr 24 2020 | EGLT | Zyla Life Sciences | Pauls Matthew | Director | Buy | M | 1.75 | 6,667 | 11,667 | 6,667 | 0 to 6.7 K |
Apr 24 2020 | EGLT | Zyla Life Sciences | McInnis Joe | Director | Option Exercise | M | 0.00 | 6,667 | 0 | 13,333 | |
Apr 24 2020 | EGLT | Zyla Life Sciences | McInnis Joe | Director | Payment of Exercise | F | 1.75 | 952 | 1,666 | 5,715 | 6.7 K to 5.7 K (-14.28 %) |
Apr 24 2020 | EGLT | Zyla Life Sciences | McInnis Joe | Director | Buy | M | 1.75 | 6,667 | 11,667 | 6,667 | 0 to 6.7 K |
Mar 26 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Option Exercise | M | 0.00 | 29,000 | 0 | 0 | |
Mar 26 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Option Exercise | M | 0.00 | 33,000 | 0 | 0 | |
Mar 26 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Payment of Exercise | F | 1.60 | 17,038 | 27,261 | 44,962 | 62 K to 45 K (-27.48 %) |
Mar 26 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Buy | M | 1.60 | 29,000 | 46,400 | 62,000 | 33 K to 62 K (+87.88 %) |
Mar 26 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Buy | M | 1.60 | 33,000 | 52,800 | 33,000 | 0 to 33 K |
Mar 26 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Option Exercise | M | 0.00 | 14,334 | 0 | 0 | |
Mar 26 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
Mar 26 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Payment of Exercise | F | 1.60 | 9,435 | 15,096 | 24,899 | 34.3 K to 24.9 K (-27.48 %) |
Mar 26 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Buy | M | 1.60 | 14,334 | 22,934 | 34,334 | 20 K to 34.3 K (+71.67 %) |
Mar 26 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Buy | M | 1.60 | 20,000 | 32,000 | 20,000 | 0 to 20 K |
Mar 05 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Option Exercise | A | 1.50 | 84,700 | 127,050 | 84,700 | |
Mar 05 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Grant | A | 0.00 | 58,000 | 0 | 58,000 | 0 to 58 K |
Mar 05 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Option Exercise | A | 1.50 | 116,400 | 174,600 | 116,400 | |
Mar 05 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Grant | A | 0.00 | 79,800 | 0 | 79,800 | 0 to 79.8 K |
Mar 05 2020 | EGLT | Zyla Life Sciences | SMITH TODD N | President and CEO | Option Exercise | A | 1.50 | 241,500 | 362,250 | 241,500 | |
Mar 05 2020 | EGLT | Zyla Life Sciences | SMITH TODD N | President and CEO | Grant | A | 0.00 | 165,500 | 0 | 165,500 | 0 to 165.5 K |
Mar 05 2020 | EGLT | Zyla Life Sciences | Walbert Timothy P | Director | Grant | A | 0.00 | 13,620 | 0 | 13,620 | 0 to 13.6 K |
Mar 05 2020 | EGLT | Zyla Life Sciences | Smiley Andrea Heslin | Director | Grant | A | 0.00 | 13,620 | 0 | 13,620 | 0 to 13.6 K |
Mar 05 2020 | EGLT | Zyla Life Sciences | Pauls Matthew | Director | Grant | A | 0.00 | 13,620 | 0 | 13,620 | 0 to 13.6 K |
Mar 05 2020 | EGLT | Zyla Life Sciences | McInnis Joe | Director | Grant | A | 0.00 | 13,620 | 0 | 13,620 | 0 to 13.6 K |
Mar 05 2020 | EGLT | Zyla Life Sciences | Phillips Gary M. | Director | Grant | A | 0.00 | 13,620 | 0 | 13,620 | 0 to 13.6 K |
Mar 02 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Option Exercise | M | 0.00 | 18,810 | 0 | 0 | |
Mar 02 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Option Exercise | M | 0.00 | 21,285 | 0 | 0 | |
Mar 02 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Payment of Exercise | F | 1.50 | 10,805 | 16,208 | 29,290 | 40.1 K to 29.3 K (-26.95 %) |
Mar 02 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Buy | M | 1.50 | 18,810 | 28,215 | 40,095 | 21.3 K to 40.1 K (+88.37 %) |
Mar 02 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Buy | M | 1.50 | 21,285 | 31,928 | 21,285 | 0 to 21.3 K |
Mar 02 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Option Exercise | M | 0.00 | 32,670 | 0 | 0 | |
Mar 02 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Option Exercise | M | 0.00 | 43,065 | 0 | 0 | |
Mar 02 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Payment of Exercise | F | 1.50 | 20,812 | 31,218 | 54,923 | 75.7 K to 54.9 K (-27.48 %) |
Mar 02 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Buy | M | 1.50 | 32,670 | 49,005 | 75,735 | 43.1 K to 75.7 K (+75.86 %) |
Mar 02 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Buy | M | 1.50 | 43,065 | 64,598 | 43,065 | 0 to 43.1 K |
Jan 10 2020 | EGLT | Zyla Life Sciences | Riva Ridge Capital Management ... | Sell | S | 2.50 | 50,000 | 125,000 | 938,661 | 988.7 K to 938.7 K (-5.06 %) | |
Jan 10 2020 | EGLT | Zyla Life Sciences | Riva Ridge Capital Management ... | Sell | S | 2.50 | 250,000 | 625,000 | 988,661 | 1.2 M to 988.7 K (-20.18 %) | |
Jan 02 2020 | EGLT | Zyla Life Sciences | SMITH TODD N | President and CEO | Option Exercise | A | 2.37 | 180,000 | 426,600 | 180,000 | |
Jan 02 2020 | EGLT | Zyla Life Sciences | Radie Robert S | Principal Financial ... | Option Exercise | M | 0.00 | 66,000 | 0 | 0 | |
Jan 02 2020 | EGLT | Zyla Life Sciences | Radie Robert S | Principal Financial ... | Option Exercise | M | 0.00 | 66,000 | 0 | 0 | |
Jan 02 2020 | EGLT | Zyla Life Sciences | Radie Robert S | Principal Financial ... | Payment of Exercise | F | 2.50 | 55,085 | 137,713 | 76,915 | 132 K to 76.9 K (-41.73 %) |
Jan 02 2020 | EGLT | Zyla Life Sciences | Radie Robert S | Principal Financial ... | Buy | M | 2.50 | 66,000 | 165,000 | 132,000 | 66 K to 132 K (+100.00 %) |
Jan 02 2020 | EGLT | Zyla Life Sciences | Radie Robert S | Principal Financial ... | Buy | M | 2.50 | 66,000 | 165,000 | 66,000 | 0 to 66 K |
Oct 24 2019 | EGLT | Zyla Life Sciences | SMITH TODD N | President and CEO | Grant | A | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
Jul 03 2019 | EGLT | Zyla Life Sciences | Capital Royalty L.P. | 10% Owner | Option Exercise | J | 0.00 | 2,436,459 | 244 | 2,436,459 | |
Jul 03 2019 | EGLT | Zyla Life Sciences | Capital Royalty L.P. | 10% Owner | Option Exercise | J | 0.00 | 2,436,459 | 244 | 0 | |
Jul 03 2019 | EGLT | Zyla Life Sciences | Capital Royalty L.P. | 10% Owner | Buy | J | 0.00 | 4,586,874 | 0 | 4,586,874 | 0 to 4.6 M |
Jul 03 2019 | EGLT | Zyla Life Sciences | Capital Royalty L.P. | 10% Owner | Sell | J | 0.00 | 4,586,874 | 0 | 0 | 4.6 M to 0 (-100.00 %) |
Jul 01 2019 | EGLT | Zyla Life Sciences | Wilkins H Jeffrey | SVP and Chief Medic ... | Grant | A | 0.00 | 190,000 | 0 | 190,000 | 0 to 190 K |
Jun 20 2019 | EGLT | Zyla Life Sciences | Phillips Gary M. | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Apr 24 2019 | EGLT | Egalet Corp | Pauls Matthew | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Apr 24 2019 | EGLT | Egalet Corp | McInnis Joe | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Apr 24 2019 | EGLT | Egalet Corp | Smiley Andrea Heslin | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Apr 24 2019 | EGLT | Egalet Corp | Walbert Timothy P | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Mar 28 2019 | EGLT | Egalet Corp | TIMMINS MEGAN C. | General Counsel | Grant | A | 0.00 | 20,000 | 0 | 63,000 | 43 K to 63 K (+46.51 %) |
Mar 28 2019 | EGLT | Egalet Corp | TIMMINS MEGAN C. | General Counsel | Grant | A | 0.00 | 43,000 | 0 | 43,000 | 0 to 43 K |
Mar 28 2019 | EGLT | Egalet Corp | Shea Patrick M | Chief Commercial Of ... | Grant | A | 0.00 | 25,000 | 0 | 90,000 | 65 K to 90 K (+38.46 %) |
Mar 28 2019 | EGLT | Egalet Corp | Shea Patrick M | Chief Commercial Of ... | Grant | A | 0.00 | 65,000 | 0 | 65,000 | 0 to 65 K |
Mar 28 2019 | EGLT | Egalet Corp | Strobeck Mark | Chief Operating Off ... | Grant | A | 0.00 | 33,000 | 0 | 120,000 | 87 K to 120 K (+37.93 %) |
Mar 28 2019 | EGLT | Egalet Corp | Strobeck Mark | Chief Operating Off ... | Grant | A | 0.00 | 87,000 | 0 | 87,000 | 0 to 87 K |
Mar 28 2019 | EGLT | Egalet Corp | Radie Robert S | President and CEO | Grant | A | 0.00 | 66,000 | 0 | 238,000 | 172 K to 238 K (+38.37 %) |
Mar 28 2019 | EGLT | Egalet Corp | Radie Robert S | President and CEO | Grant | A | 0.00 | 172,000 | 0 | 172,000 | 0 to 172 K |
Feb 04 2019 | EGLT | Egalet Corp | ROCHE ROBERT P JR | Director | Option Exercise | D | 0.60 | 75,000 | 45,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | ROCHE ROBERT P JR | Director | Option Exercise | D | 2.38 | 58,133 | 138,357 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | ROCHE ROBERT P JR | Director | Option Exercise | D | 7.96 | 26,282 | 209,205 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | NICOLAIDES NICHOLAS C | Director | Option Exercise | D | 0.60 | 75,000 | 45,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | NICOLAIDES NICHOLAS C | Director | Option Exercise | D | 2.38 | 58,133 | 138,357 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | NICOLAIDES NICHOLAS C | Director | Option Exercise | D | 4.98 | 29,666 | 147,737 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | NICOLAIDES NICHOLAS C | Director | Option Exercise | D | 12.08 | 10,000 | 120,800 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | NICOLAIDES NICHOLAS C | Director | Option Exercise | D | 11.46 | 20,000 | 229,200 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 0.60 | 75,000 | 45,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 2.38 | 58,133 | 138,357 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 4.98 | 29,666 | 147,737 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 12.08 | 10,000 | 120,800 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 5.70 | 20,000 | 114,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 15.00 | 667 | 10,005 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | WEAVER GREGORY L | Director | Option Exercise | D | 12.00 | 2,083 | 24,996 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | OSBORN JOHN E | Director | Option Exercise | D | 0.60 | 75,000 | 45,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | OSBORN JOHN E | Director | Option Exercise | D | 2.38 | 58,133 | 138,357 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | OSBORN JOHN E | Director | Option Exercise | D | 4.98 | 29,666 | 147,737 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | OSBORN JOHN E | Director | Option Exercise | D | 12.08 | 10,000 | 120,800 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | OSBORN JOHN E | Director | Option Exercise | D | 11.46 | 20,000 | 229,200 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Hochberg Elaine | Director | Option Exercise | D | 3.67 | 51,817 | 190,168 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Hochberg Elaine | Director | Option Exercise | D | 0.60 | 75,000 | 45,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Smiley Andrea Heslin | Director | Option Exercise | D | 3.67 | 51,817 | 190,168 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Smiley Andrea Heslin | Director | Option Exercise | D | 0.60 | 75,000 | 45,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Varian John | Director | Option Exercise | D | 0.40 | 110,000 | 44,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Walbert Timothy P | Director | Option Exercise | D | 0.60 | 75,000 | 45,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Walbert Timothy P | Director | Option Exercise | D | 2.38 | 58,133 | 138,357 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Walbert Timothy P | Director | Option Exercise | D | 4.98 | 29,666 | 147,737 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Walbert Timothy P | Director | Option Exercise | D | 12.08 | 10,000 | 120,800 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Walbert Timothy P | Director | Option Exercise | D | 5.70 | 20,000 | 114,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Walbert Timothy P | Director | Option Exercise | D | 15.00 | 667 | 10,005 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Walbert Timothy P | Director | Option Exercise | D | 18.83 | 1,328 | 25,006 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Walbert Timothy P | Director | Sell | D | 0.00 | 150 | 0 | 0 | 150 to 0 (-100.00 %) |
Feb 04 2019 | EGLT | Egalet Corp | Shea Patrick M | Chief Commercial Of ... | Option Exercise | D | 2.38 | 80,000 | 190,400 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Shea Patrick M | Chief Commercial Of ... | Option Exercise | D | 8.11 | 80,000 | 648,800 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Shea Patrick M | Chief Commercial Of ... | Option Exercise | D | 7.55 | 127,500 | 962,625 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Shea Patrick M | Chief Commercial Of ... | Sell | D | 0.00 | 80,000 | 0 | 0 | 80 K to 0 (-100.00 %) |
Feb 04 2019 | EGLT | Egalet Corp | Shea Patrick M | Chief Commercial Of ... | Sell | D | 0.00 | 187,020 | 0 | 0 | 187 K to 0 (-100.00 %) |
Feb 04 2019 | EGLT | Egalet Corp | TIMMINS MEGAN C. | General Counsel | Option Exercise | D | 1.29 | 15,000 | 19,350 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | TIMMINS MEGAN C. | General Counsel | Option Exercise | D | 2.38 | 10,000 | 23,800 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | TIMMINS MEGAN C. | General Counsel | Option Exercise | D | 7.96 | 4,375 | 34,825 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | TIMMINS MEGAN C. | General Counsel | Option Exercise | D | 5.43 | 8,500 | 46,155 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | TIMMINS MEGAN C. | General Counsel | Sell | D | 0.00 | 80,000 | 0 | 0 | 80 K to 0 (-100.00 %) |
Feb 04 2019 | EGLT | Egalet Corp | TIMMINS MEGAN C. | General Counsel | Sell | D | 0.00 | 126,500 | 0 | 0 | 126.5 K to 0 (-100.00 %) |
Feb 04 2019 | EGLT | Egalet Corp | CARLIN BARBARA | Chief Accounting Of ... | Option Exercise | D | 2.38 | 30,000 | 71,400 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | CARLIN BARBARA | Chief Accounting Of ... | Option Exercise | D | 8.64 | 28,000 | 241,920 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | CARLIN BARBARA | Chief Accounting Of ... | Option Exercise | D | 10.98 | 17,500 | 192,150 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | CARLIN BARBARA | Chief Accounting Of ... | Option Exercise | D | 5.33 | 10,000 | 53,300 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | CARLIN BARBARA | Chief Accounting Of ... | Option Exercise | D | 13.04 | 44,000 | 573,760 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | CARLIN BARBARA | Chief Accounting Of ... | Sell | D | 0.00 | 80,000 | 0 | 0 | 80 K to 0 (-100.00 %) |
Feb 04 2019 | EGLT | Egalet Corp | CARLIN BARBARA | Chief Accounting Of ... | Sell | D | 0.00 | 105,923 | 0 | 0 | 105.9 K to 0 (-100.00 %) |
Feb 04 2019 | EGLT | Egalet Corp | Strobeck Mark | Chief Operating Off ... | Option Exercise | D | 2.38 | 100,000 | 238,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Strobeck Mark | Chief Operating Off ... | Option Exercise | D | 8.11 | 100,000 | 811,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Strobeck Mark | Chief Operating Off ... | Option Exercise | D | 8.59 | 115,000 | 987,850 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Strobeck Mark | Chief Operating Off ... | Option Exercise | D | 5.25 | 40,000 | 210,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Strobeck Mark | Chief Operating Off ... | Sell | D | 0.00 | 80,000 | 0 | 0 | 80 K to 0 (-100.00 %) |
Feb 04 2019 | EGLT | Egalet Corp | Strobeck Mark | Chief Operating Off ... | Sell | D | 0.00 | 237,080 | 0 | 0 | 237.1 K to 0 (-100.00 %) |
Feb 04 2019 | EGLT | Egalet Corp | Radie Robert S | President and CEO | Option Exercise | D | 2.38 | 150,000 | 357,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Radie Robert S | President and CEO | Option Exercise | D | 8.13 | 50,000 | 406,500 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Radie Robert S | President and CEO | Option Exercise | D | 8.11 | 150,000 | 1,216,500 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Radie Robert S | President and CEO | Option Exercise | D | 8.59 | 265,000 | 2,276,350 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Radie Robert S | President and CEO | Option Exercise | D | 5.25 | 100,000 | 525,000 | 0 | |
Feb 04 2019 | EGLT | Egalet Corp | Radie Robert S | President and CEO | Sell | D | 0.00 | 100,000 | 0 | 0 | 100 K to 0 (-100.00 %) |
Feb 04 2019 | EGLT | Egalet Corp | Radie Robert S | President and CEO | Sell | D | 0.00 | 834,900 | 0 | 0 | 834.9 K to 0 (-100.00 %) |
Jul 02 2018 | EGLT | Egalet Corp | Varian John | Director | Option Exercise | A | 0.40 | 110,000 | 44,000 | 110,000 | |
Jul 02 2018 | EGLT | Egalet Corp | Varian John | Director | Option Exercise | A | 0.40 | 110,000 | 44,000 | 110,000 | |
Jun 15 2018 | EGLT | Egalet Corp | CARLIN BARBARA | Chief Accounting Of ... | Grant | A | 0.00 | 100,000 | 0 | 185,923 | 85.9 K to 185.9 K (+116.38 %) |
Jun 15 2018 | EGLT | Egalet Corp | TIMMINS MEGAN C. | General Counsel | Grant | A | 0.00 | 125,000 | 0 | 206,500 | 81.5 K to 206.5 K (+153.37 %) |